Free Trial
Notice: This company recently went public with an IPO on Tuesday, January 7th 2025. They issued 2,300,000 shares at $4.00-$6.00 per share. We will continue to update data for DGX as it becomes available.

Quest Diagnostics (DGX) Earnings Date, Estimates & Call Transcripts

Quest Diagnostics logo
$151.31 -0.35 (-0.23%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Quest Diagnostics Latest Earnings Summary

Upcoming Q4
Earnings Date
Jan. 30Before Market OpensEstimated
Actual EPS
(Oct. 22)
$2.30 Beat By $0.04
Consensus EPS
(Oct. 22)
$2.26

Quest Diagnostics posted Q3 2024 earnings on October 22, 2024, reporting an EPS of $2.30, which beat analysts' consensus estimates of $2.26 by $0.04. Quarterly revenue rose 8.5% year-over-year to $2.49 billion, above analyst estimates of $2.43 billion. With a trailing EPS of $7.44 and a P/E Ratio of 20.34, Quest Diagnostics' earnings are expected to grow 9.10% next year, from $8.90 to $9.71 per share.

DGX Upcoming Earnings

Quest Diagnostics' next earnings date is estimated for Thursday, January 30, 2025, based off prior year's reporting schedules, with a conference call scheduled for at 8:30 AM ET. Interested parties can register for or listen to the call or dial in at 203-369-0179.

Get Quest Diagnostics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quest Diagnostics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

DGX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DGX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Quest Diagnostics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20253$2.17$2.23$2.19 
Q2 20253$2.43$2.59$2.51 
Q3 20253$2.48$2.50$2.49 
Q4 20253$2.38$2.62$2.50 
FY 202512$9.46$9.94$9.70 
Q1 20261$2.61$2.61$2.61 
Q2 20261$2.62$2.62$2.62 
Q3 20261$2.61$2.61$2.61 
Q4 20261$2.59$2.59$2.59 
FY 20264$10.43$10.43 $10.43

Quest Diagnostics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
1/30/2025
(Estimated)
-------
10/22/2024Q3 2024$2.26$2.30+$0.04$2.61$2.43B$2.49B
7/23/2024Q2 2024$2.31$2.35+$0.04$2.67$2.39B$2.40B
4/23/2024Q1 2024$1.86$2.04+$0.18$2.36$2.29B$2.37B
2/1/2024Q4 2023$2.11$2.15+$0.04$2.60$2.25B$2.29B
10/24/2023Q3 2023$2.19$2.22+$0.03$2.48$2.27B$2.30B
7/26/2023Q2 2023$2.23$2.30+$0.07$2.55$2.25B$2.34B
4/27/2023Q1 2023$1.97$2.04+$0.07$2.30$2.20B$2.33B
2/2/2023Q4 2022$1.90$1.98+$0.08$3.09$2.26B$2.33B

Quest Diagnostics Earnings - Frequently Asked Questions

Quest Diagnostics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, January 30th, 2025 based off last year's report dates. Learn more on DGX's earnings history.

Quest Diagnostics updated its FY24 earnings guidance on Tuesday, October, 22nd. The company provided EPS guidance of $8.85-$8.95 for the period, compared to the consensus estimate of $8.89. The company issued revenue guidance of $9.80-$9.85 billion, compared to the consensus revenue estimate of $9.68 billion.

In the previous quarter, Quest Diagnostics (NYSE:DGX) reported $2.30 earnings per share (EPS) to beat the analysts' consensus estimate of $2.26 by $0.04. Learn more on analysts' earnings estimate vs. DGX's actual earnings.

The conference call for Quest Diagnostics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Quest Diagnostics's latest earnings report can be read online.
Read Transcript

Quest Diagnostics's earnings report can be found in their filing with the SEC.
View SEC filing

Quest Diagnostics (NYSE:DGX) has a recorded annual revenue of $9.25 billion.

Quest Diagnostics (NYSE:DGX) has a recorded net income of $854 million. DGX has generated $7.44 earnings per share over the last four quarters.

Quest Diagnostics (NYSE:DGX) has a trailing price-to-earnings ratio of 20.34 and a forward price-to-earnings ratio of 17.00. The price/earnings-to-growth ratio is 2.37.

Quest Diagnostics's earnings are expected to grow from $8.90 per share to $9.71 per share in the next year, which is a 9.10% increase.

More Earnings Resources from MarketBeat



This page (NYSE:DGX) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners